Vancomycin-resistant peritonitis associated with peritoneal dialysis: A cause for concern

Irish Journal of Medical Science

Volumn 171, Issue 1, 2002, Pages 42-43

  O'Riordan, A ^a   Abraham, K A ^a   Ho, J K ^a   Walshe, J J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; LINEZOLID; OXAZOLIDINONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; DRUG USE; FEMALE; HUMAN; MALE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS;

AGED; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN RESISTANCE;

EID: 0036380309     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03168942     Document Type: Article

References (22)

1. Thodis E, Passadakis P, Vargemezis V, Oreopoulos DG. Peritoneal dialysis: better than, equal to, or worse than haemodialysis? Data worth knowing before choosing a dialysis modality. Perit Dial Int 2000; 21: 25-35.
2. Troidle LK, Kliger AS, Finkelstein FO. Challenges of managing chronic peritoneal dialysis-associated peritonitis. Perit Dial Int 1999; 19: 315-8.
3. AD HOC Advisory Committee on Peritonitis Management. Peritoneal dialysis- related peritonitis treatment recommendations 1993 update. Perit Dial Int 1993; 13: 14-28.
4. Morse GD, Nairn DK, Walshe JJ. Once weekly intraperitoneal therapy for Gram-positive peritonitis. Am J Kidney Dis 1987; 10 (4): 300-5.
5. Witte W. Selective pressure by antibiotic use in livestock. Int J Antimicrob Agents 2000; 16 Suppl 1: S19-24.
6. Donskey CJ, Chowdhry TK, Hecker MT et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonised patients. New Engl J Med 2000; 343 (26): 1925-32.
7. Noble WC, Virani Z, Cree R. Co-transfer of vancomycin and other resistance genes from Enterococcus faccalis NCTC12201 to Staphylococcus aureus. FEM Microbiol Lett 1992; 72: 195-8.
8. Hayden MK. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis 2000; 31 (4): 1058-65.
9. Sanyal D, Johnson AP, George RC et al. In-vitro characteristics of glycopeptide -resistant strains of Staphylococcus epidermidis isolated from patients on CAPD. J Antimicrob Chemother 1993; 32: 267-78.
10. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase negative staphylococci. New Engl J Med 1987; 316: 927-31.
11. West TE, Walshe JJ. Bacterial exopolysaccharides ('Biofilms') in catheter-related peritonitis. Perspectives in Peritoneal Dialysis 1986; 4 (2): 1-4.
12. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (S3B): 72S-75S.
13. Kaplan AH, Gilligan PH, Facklam RR. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol 1988; 26: 1216-18.
14. Troidle L, Kliger AS, Gorban-Brennan N et al. Nine episodes of CPD-associated peritonitis with vancomycin -resistant enterococci. Kidney Int 1996; 50: 1368-72.
15. Centers for Disease Control and Prevention (CDC) USA. Recommendations for preventing vancomycin resistance. Recommendations of Hospital Infection Control Practices Advisory Committee (HIPAC). MMWR 1995; 44.
16. Keane WF, Alexander SR, Bailie GR et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 Update. Perit Dial Int 1996; 16: 557-73.
17. Leclercq R, Dutka-Malen S, Duval J et al. Vancomycin resistance gene vanC is specific to Enterococcus gallinarium. Antimicrob Agents Chemother 1992; 36: 2005.
18. Leclerq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997; 24: 545.
19. Hiramatsu K, Hanaki T, Ino T et al. Methicillin-resistant Staphylococcus aureus, clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemotber 1997; 40: 135-6.
20. Lynn WA, Clutterbuck E, Want S et al. Treatment of CAPD -peritonitis due to glycopeptide -resistant Enterococcus faecium with quinupristin-dalfopristin. Lancet 1994; 344: 1025.
21. French G. Linezolid. Int J Clin Pract 2001; 55(1): 59-63.
22. Cunney RJ, Magee C, McNamara E, Smyth EG, Walshe J. Clostridium difficile colitis associated with chronic renal failure. Nepbrol Dial Transplant 1998 Nov; 13 (11): 2842-6.